Loading...

Loading...

FDA Approves Wegovy for Adults with MASH, Liver Fibrosis
By Sofía Garduño - Mon, 08/18/2025 - 09:14
The US FDA approves Wegovy to treat adults with MASH and moderate to advanced liver fibrosis, excluding cirrhosis.
https://mexicobusiness.news/tag/wegovy
More Health
Ozempic Reduces Kidney Decline in Type 2 Diabetes Patients
By Anmol Motwani - Wed, 05/29/2024 - 11:56
Semaglutide improves kidney function and reduces cardiovascular risks in Type 2 diabetes, a critical issue in global healthcare.
Genetic Profile Could Predict Response to Weight-Loss Drug Wegovy
By MBN Staff - Fri, 05/24/2024 - 10:40
Research reveals specific genetic profiles could predict better responses to Novo Nordisk's weight-loss drug Wegovy among patients with obesity.
Novo Nordisk To Buy Cardior Pharmaceutical for US$1.1B
By MBN Staff - Wed, 03/27/2024 - 16:53
Novo Nordisk is set to acquire Cardior Pharmaceutical for US$1.1B, strengthening its cardiovascular pipeline and diversifying therapeutics.
Diabetes and Weight-Loss Drugs May Boost Hip Replacement Recovery
By MBN Staff - Tue, 02/13/2024 - 13:34
Findings suggest diabetes and weight-loss drugs may aid hip replacement patients, but cautious experts call for further research.

Food Stocks Faces Losses, Birkenstock Debuts: The Week in Retail
By Mariana Allende - Thu, 10/19/2023 - 10:00
Birkenstock NYSE debut falters; Coca-Cola and Bimbo face losses linked to weight-loss drugs. More in this Weekly Roundup!
Weight-Loss Medications Impact Coca-Cola, PepsiCo and Food Stocks
By Mariana Allende - Mon, 10/16/2023 - 17:30
Novo Nordisk’s weight-loss medication is shifting consumer behavior, which is causing losses for food and beverage brands.